Quantcast

Latest Bcl-2 Stories

2015-01-07 12:26:43

- First Patient Dosed in the "Wolverine" Phase II Trial Evaluating ProNAi's BCL2 Targeting DNAi(®) Therapeutic PNT2258 - VANCOUVER, BC and PLYMOUTH, MI, Jan.

2014-06-09 14:34:42

Follicular lymphoma, a B cell lymphoma, is an incurable form of non-Hodgkin lymphoma that is diagnosed each year in 120,000 people worldwide.

2014-04-23 08:31:41

- Investigators to Present Clinical Trial Findings Evaluating Compounds in Multiple Tumor Types NORTH CHICAGO, Ill., April 23, 2014 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that

2014-01-08 17:07:21

Walter and Eliza Hall Institute researchers have discovered a promising strategy for treating cancers that are caused by one of the most common cancer-causing changes in cells.

2013-07-09 11:33:27

Pancreatic cancer is one of the most deadly and intractable forms of cancer, with a 5-year survival rate of only 6%.

New Compound BH3 Mimetics Future Of Breast Cancer Treatment
2013-07-09 09:40:18

Scientists from Melbourne, Australia recently discovered compounds known as BH3-mimetics currently being researched to treat leukemia may also be effective in treating breast cancer.

2013-04-17 17:24:41

A new, pre-clinical study by researchers at Virginia Commonwealth University Massey Cancer Center suggests that a novel drug combination could lead to profound leukemia cell death by disrupting the function of two major pro-survival proteins.

2013-01-23 12:06:07

Melbourne researchers have discovered that the death of immune system cells is an important safeguard against the development of diseases such as type 1 diabetes, rheumatoid arthritis and lupus, which occur when the immune system attacks the body's own tissues.


Word of the Day
upstander
  • A person who stands up for something, as contrasted to a bystander who remains inactive.
  • One of the upright handlebars on a traditional Inuit sled.
The word 'upstander' in the first sense here is a play on the word 'bystander' and the idea of 'standing up' for something.